Devices/Recall·openFDA/device

Medtronic Perfusion Systems — Class II: Medtronic DLP Retrograde Cannula Manual-Inflate Silicone Body 15FR, Model 94725; Cardi

MediumPublished May 27, 2026· AI-analyzed Jun 1, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Medtronic Perfusion Systems has initiated a Class II recall for certain lots of the Medtronic DLP Retrograde Cannula (Model 94725) due to a potential breach in the sterile barrier.

Who it affects

This recall affects Medtronic Perfusion Systems and healthcare providers utilizing manual-inflate silicone body retrograde cannulae during cardiopulmonary bypass procedures.

Why it matters

A sterile barrier breach compromises the aseptic nature of the device, which may increase the risk of infection in surgical settings. Regulatory teams should view this as a failure of packaging integrity or manufacturing controls, potentially requiring an investigation into seals, transport durability, or material compatibility to prevent recurrence.

Practical takeaway

QA and supply chain teams should immediately identify and quarantine specific lots of Model 94725. Conduct a thorough review of sterile barrier integrity testing and packaging validation protocols to identify potential failure modes in manual-inflate silicone catheters.

FDA source material

Class II. Reason: Certain lots of product have the potential for a sterile barrier breach.. Product: Medtronic DLP Retrograde Cannula Manual-Inflate Silicone Body 15FR, Model 94725; Cardiopulmonary bypass vascular catheter. Firm: Medtronic Perfusion Systems (Brooklyn Park MN United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.